Quick Takeaways
- Christopher Martell has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $2,902,260.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Christopher Martell
- Location
- Needham, MA
- Summary
- The estimated net worth of Christopher Martell is at least $2,902,260 dollars as of 26 Jun 2025. Christopher Martell is the Director of Candel Therapeutics, Inc. and owns shares of Candel Therapeutics, Inc. (CADL) stock worth about $2.9M.
- Signature
- /s/ Charles Schoch, as Attorney-In-Fact for Christopher Martell
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Christopher Martell and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Candel Therapeutics, Inc. ($2,902,260).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Christopher Martell
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CADL | Candel Therapeutics, Inc. | Director | $2,902,260 | 25 Jun 2025 |
Insider Transactions Reported by Christopher Martell:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.